Evidence map›Paper›PMID 33794647›Full record

ArticleCirculation. Genomic and precision medicine2021

Homozygous

Mohammed Almannai, Shiyu Luo, Eissa Faqeih, Fuad Almutairi, Qifei Li, Pankaj B Agrawal

Open access · bronzeAbstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Circulation. Genomic and precision medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.8field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Identification ofDiagnostics (Basel, Switzerland) · 2023
    Article
  3. Article
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Mohammed AlmannaiSection of Medical Genetics, Children Specialized Hospital, King Fahad Medica City, Riyadh, Saudi Arabia (M.A., E.F.).
Shiyu LuoDivision of Newborn Medicine (S.L., Q.L., P.B.A.), Boston Children's Hospital and Harvard Medical School, Boston, MA.
Eissa FaqeihSection of Medical Genetics, Children Specialized Hospital, King Fahad Medica City, Riyadh, Saudi Arabia (M.A., E.F.).
Fuad AlmutairiGenetics and Precision Medicine Department, King Abdulaziz Medical City, Riyadh, Saudi Arabia (F.A.).
Qifei LiDivision of Newborn Medicine (S.L., Q.L., P.B.A.), Boston Children's Hospital and Harvard Medical School, Boston, MA.
Pankaj B AgrawalDivision of Newborn Medicine (S.L., Q.L., P.B.A.), Boston Children's Hospital and Harvard Medical School, Boston, MA.
Boston Children's Hospital · USKing Fahd Medical City · SAKing Saud bin Abdulaziz University for Health Sciences · SA

Funding

SPEG is Critical in Skeletal Muscle Development and FunctionR01AR068429 · NIAMS · BOSTON CHILDREN'S HOSPITAL · PI AGRAWAL, PANKAJ B · 2015 to 2019
$1.9M
NIAMS NIH HHS R01 AR068429
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AdolescentCardiomyopathy, DilatedChildChild, PreschoolElectrocardiographyFemaleGene DeletionHomozygoteHumansInfantInfant, NewbornMaleMitral Valve InsufficiencyMuscle ProteinsProtein Serine-Threonine KinasesVentricular Function, LeftMuscle ProteinsProtein Serine-Threonine KinasesSPEG protein, humancardiomyopathyexomeheart failuremitral valvesibling

Identifiers

PMID33794647
PMCPMC8058307
OpenAlexW3144832360

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.